Transition Letter Agreement between Azenta Life Sciences and Lindon G. Robertson (December 2023)
Azenta Life Sciences and Lindon G. Robertson have agreed that Mr. Robertson will retire from the company, with his last day of employment set for February 16, 2024. Until that date, he will serve as Advisor to the CEO, reporting directly to the CEO and providing transitional support. Upon his departure, he will receive a pro-rated performance bonus for his service from October 1, 2023, to February 16, 2024. The agreement requires Mr. Robertson to confirm his acceptance by signing and returning the letter by December 8, 2023.
Exhibit 10.1
December 4, 2023
VIA EMAIL
Lindon G. Robertson
Re: Transition Letter Agreement
Dear Lindon:
This Transition Letter Agreement confirms our recent discussions regarding your retirement plans from Azenta Life Sciences (“Azenta”). We have agreed that your last date of employment will be on February 16, 2024. Effective immediately and until that date, your role will be modified to Advisor to the CEO. In this role you will continue to report directly to me and provide transitional support as requested. In recognition of your multiple contributions, together with your final payment you will receive the pro-rated performance bonus (PBVC) at target for service from October 1, 2023, to February 16, 2024. I appreciate all your hard work and ensuring smooth transition in the next couple of months.
Please sign this Transition Letter Agreement document as confirmation of your agreement with the conditions outlined above and return to Olga Pirogova by December 8, 2023.
Sincerely,
/s/ Steve Schwartz
Steve Schwartz
President and Chief Executive Officer
Azenta Life Sciences
Accepted and Agreed to:
| | |
/s/ Lindon G. Robertson | | |
Lindon G. Robertson | | |
| | |
Date: | December 12, 2023 | |
